GSII - GENERAL SURGICAL INNOVATIONS, INC. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GSII - GENERAL SURGICAL INNOVATIONS, INC.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Epics who wrote (113)	4/17/1998 11:42:00 AM
From: Lighthouse	Read Replies (2) of 211

Still here. The following statements represent the authors own opinion. Such statements are not guaranteed to be accurate/helpful/truthful. Investing involves risk of capital - be careful (and that goes doubly for reading information posted from an unknown!) Missed the conference call, but the 3rd qtr press release and the JNJ non exclusive situation told the story. Cardio and vascular sales approached $500,000, which is a good showing and up substaintialy from the last quarter. GSI appears to have a good product in the Saph-Trak (hands-free and quick), but the market is getting crowded. I would like to see several more quarters of sequentially higher cardio sales before I breath easier. Also Baxter purchased no product during the qtr, which may help the 4th qtr a little. Company is blocking and tackling to try and regain momentum. Leveraging distributors to get more feet on the street and market presence. I would expect that more deals will be announced over the next several quarters, but nothing major. Additional product announcements may be made, but again nothing major. GSI has plenty of 410 k indications to keep them busy for a long time. Patent Interference case with GDT is in arbitration this week. Should know on this one within a month or two. A positive ruling here would be a good milestone. Other litigation still lingers in the August/September time frame (unless it slips again). No one knows what GDT has planned for Origin's balloon division. GDT has stated they want a cardio focus (surprise). Where this leaves the existing sales base for balloons (80,000 hernia balloons per annum) is an excellent question. Lots of litigation with GSI in a division that GDT has stated is not "core" Could a deal be worked out??????? Cash at $40M is still supporting the price. If the company can continue to show sequential revenue gains then the technology value of the company will rise quickly. Until then its a show me situation. What was your take on the quarter? Sorry for being so long winded. Regards,

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next